US Stock MarketDetailed Quotes

Verrica Pharmaceuticals (VRCA)

Watchlist
  • 7.245
  • -0.125-1.70%
Trading May 14 14:39 ET
124.46MMarket Cap-6.59P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Verrica Pharmaceuticals (VRCA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
27.72%-9.16M
71.07%-17.63M
71.42%-4.59M
213.17%9.69M
38.60%-10.04M
36.45%-12.68M
-57.94%-60.93M
-10.73%-16.06M
42.22%-8.56M
-250.35%-16.36M
Net income from continuing operations
0.62%-9.68M
76.64%-17.89M
50.17%-8.07M
98.80%-274K
101.19%204K
52.08%-9.74M
-14.31%-76.58M
34.18%-16.2M
7.83%-22.86M
-56.38%-17.19M
Operating gains losses
----
-131.82%-869K
-108.84%-229K
--34K
---420K
---254K
7.65%2.73M
4.60%2.59M
--0
----
Depreciation and amortization
-6.73%194K
-38.46%781K
-24.90%190K
-46.20%184K
-40.42%199K
-38.82%208K
51.79%1.27M
16.59%253K
62.86%342K
61.35%334K
Other non cash items
115.80%1.45M
48.73%3.28M
120.80%828K
31.01%1.09M
34.11%692K
38.92%671K
172.35%2.21M
-20.55%375K
--832K
--516K
Change In working capital
55.95%-2.02M
-408.44%-6.25M
149.08%2.01M
-28.01%7.93M
-385.45%-11.61M
-82.64%-4.59M
-79.44%2.03M
-184.06%-4.09M
4,021.71%11.02M
-152.32%-2.39M
-Change in receivables
56.67%-2.42M
-222.61%-5.32M
1,423.29%1.93M
-2.29%10.04M
-348.11%-11.72M
-75.51%-5.58M
210.44%4.34M
57.56%-146K
363.58%10.28M
-2,135.04%-2.62M
-Change in inventory
--262K
----
----
--218K
---59K
--0
----
----
--0
----
-Change in prepaid assets
-20.70%433K
76.60%-264K
172.78%1.01M
-1,953.10%-2.09M
180.71%272K
142.82%546K
-292.16%-1.13M
188.33%371K
106.00%113K
-120.74%-337K
-Change in payables and accrued expense
-189.42%-465K
-31.67%-1.14M
102.05%87K
-270.15%-1.24M
-178.91%-505K
-74.26%520K
-106.39%-862K
-174.57%-4.25M
-86.97%727K
-79.59%640K
-Change in other current liabilities
-9.21%-83K
2.17%-315K
-22.39%-82K
18.56%-79K
1.27%-78K
3.80%-76K
-10.65%-322K
0.00%-67K
-25.97%-97K
-8.22%-79K
-Change in other working capital
--249K
--782K
---782K
--1.08M
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
27.72%-9.16M
71.07%-17.63M
71.42%-4.59M
213.17%9.69M
38.60%-10.04M
36.45%-12.68M
-57.94%-60.93M
-10.73%-16.06M
42.22%-8.56M
-250.35%-16.36M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
94.75%-19K
103.52%8K
75.38%-16K
81.36%-11K
Net PPE purchase and sale
----
--0
--0
--0
----
----
94.75%-19K
103.52%8K
75.38%-16K
81.36%-11K
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
--0
--0
--0
94.75%-19K
103.52%8K
75.38%-16K
81.36%-11K
Financing cash flow
Cash flow from continuing financing activities
97.04%-120K
-96.17%1.45M
-65.40%13.64M
-903.53%-3.98M
-549.22%-4.16M
-513.77%-4.06M
-49.16%37.73M
140,907.14%39.43M
-100.90%-397K
-661.90%-640K
Net issuance payments of debt
97.26%-111K
-5,116.67%-48.2M
-9,527.27%-36.01M
-1,735.94%-3.98M
-1,351.51%-4.16M
-510.08%-4.06M
-102.10%-924K
-1,526.09%-374K
-100.49%-217K
--332K
Net common stock issuance
----
17.80%50.07M
----
----
----
----
40.27%42.5M
3,963,800.00%39.64M
--0
--0
Proceeds from stock option exercised by employees
----
--0
--0
--0
--0
--0
2,114.29%155K
--1K
--0
--150K
Net other financing activities
---9K
89.51%-420K
----
----
----
----
-2,175.00%-4M
-89,966.67%-2.7M
-195.08%-180K
----
Cash from discontinued financing activities
Financing cash flow
97.04%-120K
-96.17%1.45M
-65.40%13.64M
-903.53%-3.98M
-549.22%-4.16M
-513.77%-4.06M
-49.16%37.73M
146,122.22%39.43M
-100.90%-397K
-661.90%-640K
Net cash flow
Beginning cash position
-34.93%30.15M
-33.38%46.33M
-8.11%21.1M
-51.78%15.4M
-39.53%29.6M
-33.38%46.33M
102.92%69.55M
-72.77%22.96M
-42.09%31.93M
-18.37%48.94M
Current changes in cash
44.53%-9.28M
30.30%-16.18M
-61.28%9.05M
163.55%5.7M
16.52%-14.2M
18.80%-16.73M
-165.82%-23.22M
258.32%23.37M
-130.76%-8.97M
-253.47%-17.01M
End cash Position
-29.50%20.86M
-34.93%30.15M
-34.93%30.15M
-8.11%21.1M
-51.78%15.4M
-39.53%29.6M
-33.38%46.33M
-33.38%46.33M
-72.77%22.96M
-42.09%31.93M
Free cash flow
27.72%-9.16M
71.08%-17.63M
71.42%-4.59M
212.96%9.69M
38.64%-10.04M
36.45%-12.68M
-56.54%-60.95M
-9.03%-16.06M
42.36%-8.57M
-246.21%-16.37M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 27.72%-9.16M71.07%-17.63M71.42%-4.59M213.17%9.69M38.60%-10.04M36.45%-12.68M-57.94%-60.93M-10.73%-16.06M42.22%-8.56M-250.35%-16.36M
Net income from continuing operations 0.62%-9.68M76.64%-17.89M50.17%-8.07M98.80%-274K101.19%204K52.08%-9.74M-14.31%-76.58M34.18%-16.2M7.83%-22.86M-56.38%-17.19M
Operating gains losses -----131.82%-869K-108.84%-229K--34K---420K---254K7.65%2.73M4.60%2.59M--0----
Depreciation and amortization -6.73%194K-38.46%781K-24.90%190K-46.20%184K-40.42%199K-38.82%208K51.79%1.27M16.59%253K62.86%342K61.35%334K
Other non cash items 115.80%1.45M48.73%3.28M120.80%828K31.01%1.09M34.11%692K38.92%671K172.35%2.21M-20.55%375K--832K--516K
Change In working capital 55.95%-2.02M-408.44%-6.25M149.08%2.01M-28.01%7.93M-385.45%-11.61M-82.64%-4.59M-79.44%2.03M-184.06%-4.09M4,021.71%11.02M-152.32%-2.39M
-Change in receivables 56.67%-2.42M-222.61%-5.32M1,423.29%1.93M-2.29%10.04M-348.11%-11.72M-75.51%-5.58M210.44%4.34M57.56%-146K363.58%10.28M-2,135.04%-2.62M
-Change in inventory --262K----------218K---59K--0----------0----
-Change in prepaid assets -20.70%433K76.60%-264K172.78%1.01M-1,953.10%-2.09M180.71%272K142.82%546K-292.16%-1.13M188.33%371K106.00%113K-120.74%-337K
-Change in payables and accrued expense -189.42%-465K-31.67%-1.14M102.05%87K-270.15%-1.24M-178.91%-505K-74.26%520K-106.39%-862K-174.57%-4.25M-86.97%727K-79.59%640K
-Change in other current liabilities -9.21%-83K2.17%-315K-22.39%-82K18.56%-79K1.27%-78K3.80%-76K-10.65%-322K0.00%-67K-25.97%-97K-8.22%-79K
-Change in other working capital --249K--782K---782K--1.08M------------------------
Cash from discontinued investing activities
Operating cash flow 27.72%-9.16M71.07%-17.63M71.42%-4.59M213.17%9.69M38.60%-10.04M36.45%-12.68M-57.94%-60.93M-10.73%-16.06M42.22%-8.56M-250.35%-16.36M
Investing cash flow
Cash flow from continuing investing activities 00094.75%-19K103.52%8K75.38%-16K81.36%-11K
Net PPE purchase and sale ------0--0--0--------94.75%-19K103.52%8K75.38%-16K81.36%-11K
Cash from discontinued investing activities
Investing cash flow --0--0--0--0--0--094.75%-19K103.52%8K75.38%-16K81.36%-11K
Financing cash flow
Cash flow from continuing financing activities 97.04%-120K-96.17%1.45M-65.40%13.64M-903.53%-3.98M-549.22%-4.16M-513.77%-4.06M-49.16%37.73M140,907.14%39.43M-100.90%-397K-661.90%-640K
Net issuance payments of debt 97.26%-111K-5,116.67%-48.2M-9,527.27%-36.01M-1,735.94%-3.98M-1,351.51%-4.16M-510.08%-4.06M-102.10%-924K-1,526.09%-374K-100.49%-217K--332K
Net common stock issuance ----17.80%50.07M----------------40.27%42.5M3,963,800.00%39.64M--0--0
Proceeds from stock option exercised by employees ------0--0--0--0--02,114.29%155K--1K--0--150K
Net other financing activities ---9K89.51%-420K-----------------2,175.00%-4M-89,966.67%-2.7M-195.08%-180K----
Cash from discontinued financing activities
Financing cash flow 97.04%-120K-96.17%1.45M-65.40%13.64M-903.53%-3.98M-549.22%-4.16M-513.77%-4.06M-49.16%37.73M146,122.22%39.43M-100.90%-397K-661.90%-640K
Net cash flow
Beginning cash position -34.93%30.15M-33.38%46.33M-8.11%21.1M-51.78%15.4M-39.53%29.6M-33.38%46.33M102.92%69.55M-72.77%22.96M-42.09%31.93M-18.37%48.94M
Current changes in cash 44.53%-9.28M30.30%-16.18M-61.28%9.05M163.55%5.7M16.52%-14.2M18.80%-16.73M-165.82%-23.22M258.32%23.37M-130.76%-8.97M-253.47%-17.01M
End cash Position -29.50%20.86M-34.93%30.15M-34.93%30.15M-8.11%21.1M-51.78%15.4M-39.53%29.6M-33.38%46.33M-33.38%46.33M-72.77%22.96M-42.09%31.93M
Free cash flow 27.72%-9.16M71.08%-17.63M71.42%-4.59M212.96%9.69M38.64%-10.04M36.45%-12.68M-56.54%-60.95M-9.03%-16.06M42.36%-8.57M-246.21%-16.37M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.74%
Sample Name
Sample Code
 +14.84%
Sample Name
Sample Code
 +14.09%
4
United States Oil Fund LP
USO
+13.12%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+10.40%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +13.16%
Sample Name
Sample Code
 +9.32%
Sample Name
Sample Code
 +9.07%
4
Hesai
HSAI
+7.87%
5
NIO Inc
NIO
+7.24%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -